Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Reexamination Certificate
2007-07-24
2007-07-24
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
C424S085100
Reexamination Certificate
active
09890266
ABSTRACT:
A tumor vaccine which comprises a microparticle or a lysate prepared from a solidified tumor material selected from the group consisting of a tumor tissue, a tumor cell, and a component thereof, and at least one cytokine and/or cytokine-inducing agent (e.g., a granulocyte-macrophage-colony stimulating factor and/or interleukin-2 and the like), and optionally an adjuvant. The vaccine can be easily prepared and widely applied for prevention of recurrence, inhibition of metastasis and therapeutic treatment regardless of a type of a tumor, and has excellent antitumor effect.
REFERENCES:
patent: 5861159 (1999-01-01), Pardoll et al.
patent: 1119459 (1996-03-01), None
patent: 00805910 (2000-02-01), None
patent: 0690125 (1996-11-01), None
patent: 90/03183 (1990-04-01), None
patent: 90/11085 (1990-10-01), None
patent: 96/01611 (1996-01-01), None
patent: 98/16238 (1998-04-01), None
Entry of microparticle in Meririam-Webster Online downloaded on Mar. 13, 2005 from url>>www.m-w.com.
Wordreference.com downloaded on Oct. 20, 2005, definition of homogenate.
Definition of “particle” in Merriam-Webster Online downloaded on Oct. 26, 2005.
Kwiatkowska et al., (1999, BioEssays, vol. 21, pp. 422-431).
Mescher, M., and Rogers, J., J. Immunotherapy 19(2), pp. 102-112 (1996).
Golumbek, P., et al., Cancer Res. 53, pp. 5841-5844 (1993).
Pardoll, D., Nature Medicine Vacine Suppl. vol. 4, pp. 525-531 (1998).
English Language Abstract of CN 1119459.
Pardoll, D.M., Nature Med., 4 (5Suppl.), pp. 525-531 (1998).
Nestle, F.O., et al., Nature Med., 4, pp. 328-332 (1998).
Nakanishi, T., et al., Biochem. Biophys. Res. Comm., 250, pp. 793-797 (1997).
Rosenberg, S.A., et al., Nature Med., 4, pp. 321-327 (1998).
Golumbeck, P.T., et al., Cancer Res., 53, pp. 5841-5844 (1993).
Naito, M. and Seno, S., Cell Biol. International Rep., 5, pp. 675-681 (1981).
Liu, S.Q., et al., Nature Med., 2, pp. 1283-1283 (1996).
Falo, Jr., L.D., et al., Nature Med., 1, pp. 649-653 (1996).
Kim, C., et al., Cancer Immunol. Immunother., 47, pp. 90-96 (1998).
Inaba, et al., Lecture SI-3-3, Japanese Immunology Society, Dec. 2, 1998.
Guo, Y.J., et al., Nature Med., 3, pp. 451-455 (1997).
Levitsky, H.I., et al., J. Immunol., 156, pp. 3858-3865 (1996).
English Language Abstract of CN 1119459.
Leong Kam
Liu Shu Qin
Ohno Tadao
Peng Bao Gang
Cell-Medicine, Inc.
Greenblum & Bernstein P.L.C.
Riken
Yu Misook
LandOfFree
Tumor vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3731709